A Phase I/II Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer

Read full text Summarise with VIRAT
Authors: Johns Hopkins University, Nilofer A. Azad, Eric Christenson, Rose M. Parkinson
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

A phase I/II study of PI3Kinase inhibition (copanlisib) and anti-PD-1 antibody nivolumab in relapsed/refractory solid tumors with expansions in mismatch-repair proficient (MSS) colorectal cancer.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies PI3K/AKT/mTOR signaling in cancer

Publication details

Journal / source
Vivli
Publication date
26 March 2026
Language
EN
Document type
Dataset